July 2019
Policy brief
HIV Treatment
Integrated Management of Adolescent and Adult Illness
Integrated Management of Childhood Illness
Interim Guidelines for health workers at health centre or district hospital outpatient clinic
Recommendations for a Public Health approach and considerations for policy-makers and managers
Guidance
Second Edition
Monitoring and Evaluation
Recommendations for a public health approach
HIV/AIDS Programme
Putting Asia’s HIV response back on track
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...n randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
Guidelines
June 2017
HIV strategic information for impact
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Technical Report
AIDS Medicines and diagnostics service
July 2015
HIV Treatment
Policy Brief
July 2017